MedTrace Logo

Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection

NCT04817865 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2023-11-18

No results posted yet for this study

Summary

This study is a retrospective record review to determine whether a novel multiplex PCR assay can be utilized as a screening method for UTI in patients receiving Botox injection to treat overactive bladder (OAB).

Conditions

Interventions

DIAGNOSTIC_TEST

Multiplex-PCR with Pooled Antibiotic Susceptibility Testing (M-PCR/P-AST)

M-PCR/P-AST is a dual assessment test that detects pathogenic DNA commonly associated with urinary tract infections and identifies their genotypic and phenotypic antibiotic resistance.

DIAGNOSTIC_TEST

Urine Culture

A traditional clinical UTI evaluation consisting of non-molecular standard urine culture (SUC) and sensitivity testing methods.

Sponsors & Collaborators

  • Pathnostics

    lead INDUSTRY

Principal Investigators

  • David Baunoch, PhD · Pathnostics, Inc.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-08-15
Primary Completion
2021-02-10
Completion
2023-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04817865 on ClinicalTrials.gov